ITMIG2021 – About

Organizing Committee

Malgorzata Szolkowska, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland

Edith MaromThe Chaim Sheba Medical Center, Ramat Gan, Israel

Nicolas Girard, Institut Curie, Paris, France

Andreas Rimner, Memorial Sloan Kettering Cancer Center, New York, USA

Pam Bruce, Executive Director of ITMIG, New York, USA


Scientific Committee

In alphabetical order: 

Katarzyna Blasinska, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland

Frank Detterbeck, Yale University School of Medicine, New Haven, CT, USA

Conrad Falkson, Queen’s University and Kingston Health Sciences Center, Kingston, Ontario, Canada

Nicolas Girard, Institut Curie, Paris, France

Maria Leite, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK

Edith Marom, The Chaim Sheba Medical Center, Ramat Gan, Israel

Arun RajanNational Cancer Institute, National Institutes of Health (NCI/NIH), Bethesda, USA

Andreas Rimner, Memorial Sloan Kettering Cancer Center, New York, USA

Anja Roden, Mayo Clinic Rochester, Rochester, MN, USA

Paul Van SchilAntwerp University Hospital, Edegem (Antwerp), Belgium

Malgorzata Szolkowska, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland

Alper Toker, West Virginia University Heart and Vascular Institute, USA

Important Dates

Registration Opens

April 1, 2021

Early Registration Deadline

August 31, 2021

Late Registration Deadline

October 14, 2021

Abstract Submission Deadline

July 15, 2021

Notification of Abstract Acceptance

August 15, 2021

CONFERENCE DAYS

October 16-17, 2021